LR MEDICAL: what changed
What changed
LR MEDICAL
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€87,656
2024 · €115,438-€27,782
Equity
€203,403
2024 · €116,579+€86,823
Cash
€182,534
2024 · €92,915+€89,618
Balance sheet total
€213,274
2024 · €127,849+€85,425
Largest movements
Assets
- Cash +€89,618
up €89,618 (+96.5%), from €92,915 to €182,534
mainly Net result for the year (+€87,656) and Total equity and liabilities (+€85,425)
- Tangible fixed assets -€4,499
down €4,499 (-25.8%), from €17,427 to €12,927
Equity and liabilities
- Total equity and liabilities +€85,425
up €85,425 (+66.8%), from €127,849 to €213,274
of which Equity: +€86,823
Income statement
- Gross operating margin -€41,614
down €41,614 (-26.2%), from €158,790 to €117,176
- Taxes -€19,701
down €19,701 (-44.0%), from €44,738 to €25,037
- Depreciation -€3,121
down €3,121 (-41.0%), from €7,620 to €4,499
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€115,438
Gross operating margin
-€41,614
Depreciation
+€3,121
Other operating charges
+€985
Financial income
+€260
Financial charges
+€27
Taxes
+€19,701
Deferred taxes and other
-€10,264
Result 2025
€87,656
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€177,274
Investment
€0
Financing
-€87,656
Cash 2024
€92,915
From operations (derived)
+€177,274
Net result for the year
+€87,656
Depreciation
+€4,499
Receivables within one year
-€41
Deferred charges and accrued income
-€265
Total equity and liabilities
+€85,425
Financing
-€87,656
Contributions, distributions and other
-€87,656
Cash 2025
€182,534
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €127,849 | €213,274 | +€85,425 | +66.8% |
| Fixed assets | 21/28 | €17,427 | €12,927 | -€4,499 | -25.8% |
| Tangible fixed assets | 22/27 | €17,427 | €12,927 | -€4,499 | -25.8% |
| Furniture and vehicles | 24 | €17,427 | €12,927 | -€4,499 | -25.8% |
| Current assets | 29/58 | €110,422 | €200,347 | +€89,925 | +81.4% |
| Amounts receivable within one year | 40/41 | - | €41 | +€41 | |
| Other amounts receivable | 41 | - | €41 | +€41 | |
| Cash at bank and in hand | 54/58 | €92,915 | €182,534 | +€89,618 | +96.5% |
| Deferred charges and accrued income | 490/1 | €17,507 | €17,772 | +€265 | +1.5% |
| Total equity and liabilities | 10/49 | €127,849 | €213,274 | +€85,425 | +66.8% |
| Equity | 10/15 | €116,579 | €203,403 | +€86,823 | +74.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €114,579 | €201,403 | +€86,823 | +75.8% |
| Distributable reserves | 133 | €114,579 | €201,403 | +€86,823 | +75.8% |
| Amounts payable | 17/49 | €21,533 | €9,871 | -€11,661 | -54.2% |
| Amounts payable after more than one year | 17 | €5,000 | - | -€5,000 | |
| Other amounts payable | 178/9 | €5,000 | - | -€5,000 | |
| Amounts payable within one year | 42/48 | €16,533 | €9,871 | -€6,661 | -40.3% |
| Trade debts | 44 | €96 | €182 | +€86 | +89.1% |
| Suppliers | 440/4 | €96 | €182 | +€86 | +89.1% |
| Taxes, remuneration and social security | 45 | €15,348 | €5,009 | -€10,339 | -67.4% |
| Taxes | 450/3 | €15,348 | €5,009 | -€10,339 | -67.4% |
| Other amounts payable | 47/48 | €1,089 | €4,681 | +€3,592 | +330% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,620 | €4,499 | -€3,121 | -41.0% |
| Other operating charges | 640/8 | €1,168 | €183 | -€985 | -84.4% |
| Gross operating margin | 9900 | €158,790 | €117,176 | -€41,614 | -26.2% |
| Operating profit (loss) | 9901 | €150,002 | €112,494 | -€37,508 | -25.0% |
| Financial income | 75/76B | - | €260 | +€260 | |
| Recurring financial income | 75 | - | €260 | +€260 | |
| Financial charges | 65/66B | €89 | €61 | -€27 | -31.0% |
| Recurring financial charges | 65 | €89 | €61 | -€27 | -31.0% |
| Profit (loss) for the period before taxes | 9903 | €149,913 | €112,693 | -€37,220 | -24.8% |
| Income taxes | 67/77 | €44,738 | €25,037 | -€19,701 | -44.0% |
| Profit (loss) for the period | 9904 | €115,438 | €87,656 | -€27,782 | -24.1% |
| Profit (loss) for the period to be appropriated | 9905 | €115,438 | €87,656 | -€27,782 | -24.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.